skip to main content

Severe eosinophilic asthma — RCPSC IM MCQ

Instant feedback + full explanation. One question, done properly.

HardRespirologySevere eosinophilic asthmaRCPSC IM

A 45-year-old woman has asthma with four prednisone-treated exacerbations in the last year despite high-dose inhaled corticosteroid-formoterol, tiotropium and adherence confirmed by pharmacy records. Spirometry shows reversible obstruction. Blood eosinophils are 0.72 x 10^9/L and FeNO is elevated. CT chest shows no bronchiectasis. What is the most appropriate next step?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DAdd a biologic targeting type 2 inflammation after confirming phenotype and access criteria

Frequent exacerbations despite optimized high-dose inhaled therapy with eosinophilia support severe type 2 asthma; biologic therapy should be considered after confirming phenotype, adherence and comorbidities.

Reference: Canadian Thoracic Society severe asthma guidance